Distler, Ute <br/><br/>
Tumor-associated CD75s- and iso-CD75s-gangliosides are potential targets for adjuvant therapy in pancreatic cancer.  [electronic resource] 

 -  Molecular cancer therapeutics  Aug 2008 
 - 2464-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1535-7163 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-08-0353  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Antibodies, Neoplasm--blood<br/>Antigens, CD--immunology<br/>Antineoplastic Agents--therapeutic use<br/>Biomarkers, Tumor--antagonists & inhibitors<br/>Chemotherapy, Adjuvant<br/>Chromatography, Thin Layer<br/>Gangliosides--antagonists & inhibitors<br/>Humans<br/>Immunohistochemistry<br/>Microscopy, Fluorescence<br/>Pancreatic Neoplasms--drug therapy<br/>Recombinant Proteins--therapeutic use<br/>Ribosome Inactivating Proteins, Type 2--therapeutic use<br/>Sialyltransferases--antagonists & inhibitors<br/>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization<br/>Toxins, Biological--therapeutic use